Previous Close | 0.9000 |
Open | 0.9000 |
Bid | 0.0000 |
Ask | 2.4000 |
Strike | 22.50 |
Expire Date | 2024-12-20 |
Day's Range | 0.9000 - 0.9000 |
Contract Range | N/A |
Volume | |
Open Interest | 2 |
On June 3, 2024, Julie Hambleton, Director at SpringWorks Therapeutics Inc (NASDAQ:SWTX), sold 4,648 shares of the company.
Badreddin Edris, the Chief Operating Officer of SpringWorks Therapeutics Inc (NASDAQ:SWTX), sold 20,000 shares of the company on June 3, 2024, according to a recent SEC filing.
On June 3, 2024, Saqib Islam, the Chief Executive Officer of SpringWorks Therapeutics Inc (NASDAQ:SWTX), executed a sale of 49,000 shares of the company.